Researchers discover potential new drug target to treat cutaneous T cell lymphoma

Sweden blocks travel from Denmark over virus fears
21 December 2020
25 Skills Every Doctor Should Possess
21 December 2020

Researchers discover potential new drug target to treat cutaneous T cell lymphoma

Cutaneous T cell lymphomas (CTCLs) are a group of non-Hodgkin lymphomas that develop from T cells and mainly impact the skin with painful lesions. The two main subtypes of CTCL are mycosis fungoides and Sézary syndrome. CTCLs are extremely rare, with approximately six cases per 1 million people each year. It is unclear how CTCL develops, and unfortunately there are limited treatment options and no cure.

Comments are closed.